- Ingird Gafanhão
- Maria Vara
- Olga Smolentseva
- Oscar Haffen Lamm
- Valliant Campagne
Taking autologous CAR Ts a step forward
Autolus is a CAR T cell therapy company building upon a modular platform that allows for the design of candidates that incorporate a range of programming capabilities. Autolus has one of the most advanced CAR T programs in clinical stage: obe-cel, an autologous CD19 CAR T with a unique binder, show
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.